A series of pyrrolo [2, 3-d] pyrimidone nucleosides were synthesized and evaluated for their ability to enhance Type 2 cytokines and to suppress Type 1 cytokines in human T cells activated in vitro. Compounds 16b, 16c, 16d, 18c, and 19b induced substantial enhancement of IL-4 (a Type 2 cytokine) levels while three compounds (16b, 16c, and 16f) showed significant suppression of IFNγ (a Type 1 cytokine) levels. The results revealed a ...
[Porcari, Anthony R.; Ptak, Roger G.; Borysko, Katherine Z.; Breitenbach, Julie M.; Vittori, Sauro; Wotring, Linda L.; Drach, John C.; Townsend, Leroy B. Journal of Medicinal Chemistry, 2000 , vol. 43, # 12 p. 2438 - 2448]